Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis

Abstract The genus Schistosoma causes a schistosomiasis which is one of the neglected tropical diseases that pose a major threat to public health in East Africa. Praziquantel (PZQ) is the first line drug to treat human schistosomiasis. However, there is scarcity of pooled and summarized data on PZQ...

Full description

Saved in:
Bibliographic Details
Main Authors: Miseganaw Sisay, Tadesse Hailu, Destaw Damtie, Kindu Geta, Lamesgen Zelalem, Degisew Misganaw
Format: Article
Language:English
Published: Nature Portfolio 2025-02-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-024-84621-8
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1823862320586031104
author Miseganaw Sisay
Tadesse Hailu
Destaw Damtie
Kindu Geta
Lamesgen Zelalem
Degisew Misganaw
author_facet Miseganaw Sisay
Tadesse Hailu
Destaw Damtie
Kindu Geta
Lamesgen Zelalem
Degisew Misganaw
author_sort Miseganaw Sisay
collection DOAJ
description Abstract The genus Schistosoma causes a schistosomiasis which is one of the neglected tropical diseases that pose a major threat to public health in East Africa. Praziquantel (PZQ) is the first line drug to treat human schistosomiasis. However, there is scarcity of pooled and summarized data on PZQ efficacy to policymakers. Articles were searched from PubMed, Google Scholar, Web of Science, and Scopus databases. In total, 87 published articles were retrieved. Only studies conducted in English that reported the efficacy of PZQ against Schistosoma mansoni, regardless of the year, and studies with more than fifty positive cases were included in the present study. Excel software was used to extract the name of the authors, the total sample size, number of cured participants, the study area, and the year of publication. The pooled efficacy of PZQ against S. mansoni was analyzed using CMA Version 2.2 software. A total of 21 studies fulfilled the inclusion criteria for the present systematic review and meta-analysis. The overall pooled efficacy of PZQ was 85.0% (95% CI: 80.0-89.0%) against S. mansoni. In subgroup analysis, the efficacy of PZQ against S. mansoni was 90.4% in Ethiopia, 71.2% in Kenya, 97.9% in Rwanda, 75.4% in Tanzania, and 68.4% in Uganda. Its heterogeneity was high (I2 = 94.8), and the there is no publication bias between studies. The overall effectiveness of PZQ against S. mansoni in East Africa is doubtful. Therefore, repeated doses should be advocated.
format Article
id doaj-art-9366f59eb0f8400fb28125daca3806ec
institution Kabale University
issn 2045-2322
language English
publishDate 2025-02-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-9366f59eb0f8400fb28125daca3806ec2025-02-09T12:35:04ZengNature PortfolioScientific Reports2045-23222025-02-011511910.1038/s41598-024-84621-8Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysisMiseganaw Sisay0Tadesse Hailu1Destaw Damtie2Kindu Geta3Lamesgen Zelalem4Degisew Misganaw5Department of Biology, College of Natural and Computational Science, Debre Tabor UniversityDepartment of Medical Laboratory Science, College of Medicine and Health Sciences, Bahir Dar UniversityDepartment of Biology, College of Science, Bahir Dar UniversityDepartment of Biology, College of Natural and Computational Science, Debre Tabor UniversityDepartment of Biology, College of Natural and Computational Science, Debre Tabor UniversityDepartment of Medical laboratory technologist, Debre Tabor Health Science CollegeAbstract The genus Schistosoma causes a schistosomiasis which is one of the neglected tropical diseases that pose a major threat to public health in East Africa. Praziquantel (PZQ) is the first line drug to treat human schistosomiasis. However, there is scarcity of pooled and summarized data on PZQ efficacy to policymakers. Articles were searched from PubMed, Google Scholar, Web of Science, and Scopus databases. In total, 87 published articles were retrieved. Only studies conducted in English that reported the efficacy of PZQ against Schistosoma mansoni, regardless of the year, and studies with more than fifty positive cases were included in the present study. Excel software was used to extract the name of the authors, the total sample size, number of cured participants, the study area, and the year of publication. The pooled efficacy of PZQ against S. mansoni was analyzed using CMA Version 2.2 software. A total of 21 studies fulfilled the inclusion criteria for the present systematic review and meta-analysis. The overall pooled efficacy of PZQ was 85.0% (95% CI: 80.0-89.0%) against S. mansoni. In subgroup analysis, the efficacy of PZQ against S. mansoni was 90.4% in Ethiopia, 71.2% in Kenya, 97.9% in Rwanda, 75.4% in Tanzania, and 68.4% in Uganda. Its heterogeneity was high (I2 = 94.8), and the there is no publication bias between studies. The overall effectiveness of PZQ against S. mansoni in East Africa is doubtful. Therefore, repeated doses should be advocated.https://doi.org/10.1038/s41598-024-84621-8Cure rateEast AfricaMeta-analysisPraziquantelSchistosoma mansoniSystematic review
spellingShingle Miseganaw Sisay
Tadesse Hailu
Destaw Damtie
Kindu Geta
Lamesgen Zelalem
Degisew Misganaw
Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
Scientific Reports
Cure rate
East Africa
Meta-analysis
Praziquantel
Schistosoma mansoni
Systematic review
title Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
title_full Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
title_fullStr Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
title_full_unstemmed Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
title_short Efficacy of single dose praziquantel against Schistosoma mansoni in East Africa: a systematic review and meta-analysis
title_sort efficacy of single dose praziquantel against schistosoma mansoni in east africa a systematic review and meta analysis
topic Cure rate
East Africa
Meta-analysis
Praziquantel
Schistosoma mansoni
Systematic review
url https://doi.org/10.1038/s41598-024-84621-8
work_keys_str_mv AT miseganawsisay efficacyofsingledosepraziquantelagainstschistosomamansoniineastafricaasystematicreviewandmetaanalysis
AT tadessehailu efficacyofsingledosepraziquantelagainstschistosomamansoniineastafricaasystematicreviewandmetaanalysis
AT destawdamtie efficacyofsingledosepraziquantelagainstschistosomamansoniineastafricaasystematicreviewandmetaanalysis
AT kindugeta efficacyofsingledosepraziquantelagainstschistosomamansoniineastafricaasystematicreviewandmetaanalysis
AT lamesgenzelalem efficacyofsingledosepraziquantelagainstschistosomamansoniineastafricaasystematicreviewandmetaanalysis
AT degisewmisganaw efficacyofsingledosepraziquantelagainstschistosomamansoniineastafricaasystematicreviewandmetaanalysis